Overview of Key Findings
- Medicare pays for the largest share (> 30%) of naloxone dispensed from retail pharmacies in non-metropolitan areas.
- Medicare-paid dispensing has grown since 2013, but from 2017-2018 dispensing growth in non-metropolitan areas slowed considerably compared to metropolitan areas (42% v 121%, respectively).
- As of 2018, the rate of naloxone dispensing to Medicare enrollees in metropolitan areas was approximately double that in non-metropolitan areas (4.9 v 2.9 per 1,000 enrollees, respectively).
This project was supported by the Federal Office of Rural Health Policy (FORHP), Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services (HHS) under cooperative agreement # U1CRH30041.
Delcher, Chris; Cheng, Yue; Sohn, Minji; Talbert, Jeffery C.; and Freeman, Patricia R., "Medicare-Paid Naloxone: Trends in Non-Metropolitan and Metropolitan Areas" (2021). Rural & Underserved Health Research Center Publications. 18.